Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 2:22 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 361–384 of 590 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Diagnostic Ultrasound System Clear all

Conditions: Phenylketonuria
Interventions: Preparative Radiation Therapy, Hepatocyte Transplant, Immunosuppression, Liver Evaluation, Neuro-psychological Assessment, Whole body Phe oxidation testing, Liver Biopsy; Radiation · Procedure · Drug + 3 more
Lead sponsor: Ira Fox; Other
Eligibility: 14 Years to 55 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2016
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Trigeminal Neuralgia
Interventions: ExAblate Transcranial treatment; Device
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 21 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Baltimore, Maryland

Conditions: Oxygen Saturation
Interventions: Observational; Device
Lead sponsor: Medtronic - MITG; Industry
Eligibility: 18 Years to 50 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Pain, Postoperative, Opioid Use
Interventions: Liposomal bupivacaine, TAP block, Deposition of saline; Drug · Procedure
Lead sponsor: University of Missouri, Kansas City; Other
Eligibility: 18 Years to 45 Years · Female only
Enrollment: 97 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2025
U.S. locations: 1
States / cities: Kansas City, Missouri

Conditions: Body Contouring
Interventions: Liposonix System (Model 2), Pre-treatment analgesia; Device · Drug
Lead sponsor: Solta Medical; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 11 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: Hayward, California

Conditions: Respiratory Distress Syndrome in Premature Infant
Interventions: High flow nasal cannula, Nasal CPAP; Procedure
Lead sponsor: Sharp HealthCare; Other
Eligibility: 23 Weeks to 28 Weeks
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: San Diego, California

Conditions: ADHF
Interventions: Lung Doppler Signals; Device
Lead sponsor: Echosense Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 3
States / cities: Detroit, Michigan • Dallas, Texas • Houston, Texas

Conditions: Chronic Kidney Disease, Secondary Hyperparathyroidism
Interventions: Contrast Enhanced Ultrasonography; Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 75 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Scars, Striae
Interventions: Ultherapy® treatment only, Ultherapy® treatment and CO2 laser treatment, CO2 Laser treatment only; Device
Lead sponsor: Ulthera, Inc; Industry
Eligibility: 21 Years to 65 Years
Enrollment: 14 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 2
States / cities: Paramus, New Jersey • Charlotte, North Carolina

Conditions: Breast Cancer, Benign Breast Condition, Breast Fibroadenoma, Breast Neoplasms, Breast Disease, Breast Cancer Female, Breast Pain, Breast Cancer Invasive, Breast Cancer Detection
Interventions: ATUSA 3D Automated Breast Ultrasound System; Device
Lead sponsor: iSono Health, Inc.; Industry
Eligibility: 18 Years to 94 Years · Female only
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 2
States / cities: Sacramento, California • Cypress, Texas

Conditions: Breast Abscess
Interventions: Standard of care breast abscess drainage, Methylene Blue, Lipid Emulsion, Insertion of optical fiber, Laser illumination, Photodynamic therapy; Procedure · Drug · Device
Lead sponsor: University of Rochester; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2032
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Deep Vein Thrombosis, Deep Vein Thrombosis, Pulmonary Embolus
Interventions: ThinkSono System; Device
Lead sponsor: ThinkSono, Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 634 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 5
States / cities: New York, New York • Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania + 2 more

Conditions: Pancreatic Cancer
Interventions: Nanoknife Irreversible Electroporation; Device
Lead sponsor: Holy Name Medical Center, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2021
U.S. locations: 1
States / cities: Teaneck, New Jersey

Conditions: Glioblastoma, Mismatch Repair Deficiency
Interventions: Pembrolizumab, Navifus Focused Ultrasound Sonification; Drug · Device
Lead sponsor: Jennifer Leddon; Other
Eligibility: 18 Years and older
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Glioblastoma Multiforme, Glioblastoma, Glioma, Brain Tumor, Neoplasms, Neoplasms, Nerve Tissue
Interventions: NaviFUS System, Lumason, Bevacizumab; Device · Drug
Lead sponsor: NaviFUS Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Esophagus
Interventions: Endoscopic Ultrasound-Guided Fine-Needle Aspiration (EUS-FNA), Contrast-Enhanced Ultrasound, Fine-Needle Aspiration, Sonazoid (Perflubutane); Procedure · Drug
Lead sponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University; Other
Eligibility: 21 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Hypertension
Interventions: TIVUS™ Renal Denervation System, Sham; Device · Other
Lead sponsor: SoniVie Inc.; Industry
Eligibility: 22 Years to 75 Years
Enrollment: 261 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 34
States / cities: Birmingham, Alabama • Scottsdale, Arizona • Jonesboro, Arkansas + 30 more

Conditions: Chronic Obstructive Pulmonary Disease, HIV, Emphysema
Interventions: blood draw, questionnaires, Lung function testing, Six-Minute walk test, Quantitative CT scans, Nasal secretion and cell collection, Echocardiogram; Procedure · Radiation
Lead sponsor: University of Pittsburgh; Other
Eligibility: 18 Years to 80 Years
Enrollment: 232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2020
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Breast Cancer
Interventions: EnVisio SmartClip, EnVisio™ Navigation System; Device
Lead sponsor: H. Lee Moffitt Cancer Center and Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Tampa, Florida

Conditions: Skin Laxity
Interventions: Ulthera Treatment; Device
Lead sponsor: Ulthera, Inc; Industry
Eligibility: 30 Years to 65 Years
Enrollment: 2 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2013
U.S. locations: 1
States / cities: Pasadena, California

Conditions: Focused Ultrasound
Interventions: Focused Ultrasound; Other
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 85 Years
Enrollment: 300 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Pancreas Cancer, Peutz-Jeghers Syndrome (PJS), Gene Mutation, Germline Mutation Carrier, Lynch Syndrome
Interventions: Secretin, MRI, Tumor marker gene test with CA19-9; Drug · Diagnostic Test · Other
Lead sponsor: Johns Hopkins University; Other
Eligibility: 18 Years and older
Enrollment: 9,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2029
U.S. locations: 9
States / cities: New Haven, Connecticut • Baltimore, Maryland • Boston, Massachusetts + 5 more

Conditions: Gastric Contents
Interventions: Ultrasonography; Diagnostic Test
Lead sponsor: Stanford University; Other
Eligibility: 2 Years to 60 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2025
U.S. locations: 1
States / cities: Stanford, California

Conditions: Localized Prostate Cancer
Interventions: Aquablation Therapy, Active Surveillance; Device · Other
Lead sponsor: PROCEPT BioRobotics; Industry
Eligibility: 45 Years and older · Male only
Enrollment: 333 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2038
U.S. locations: 27
States / cities: Chandler, Arizona • Los Angeles, California • Murrieta, California + 23 more

Search by objective public record fields.

Liver Cell Transplant for Phenylketonuria

MR Guided Focused Ultrasound (FUS) for the Treatment of Trigeminal Neuralgia

Accuracy Performance Verification of the INVOS™ PM7100 System in Adults

Stopping Opioid Overuse in Obstetrics to Halt Exposure Trial

Evaluation of Procedural Analgesia for Liposonix Treatment

Physiological Changes With High-Flow Nasal Cannula

Evaluation of the Diagnostic Value of the TPD System in Determining ADHF Causing Acute Dyspnea

Effects of Vitamin D on Renal Blood Flow, Proteinuria and Inflammation in Patients With Chronic Kidney Disease

Feasibility Study: Evaluation of the Treatment of Striae Using Ultherapy® in Combination With Laser Treatment

ATUSA Ultrasound Diagnostic Imaging for Breast Lesions Evaluation (AUDIBLE) - iSono Health

A Phase 2 Study of Methylene Blue Photodynamic Therapy for Treatment of Breast Abscesses

Determining the Validity of ThinkSono Guidance for Ultrasound Image Acquisition and Remote Detection

Ablation of Unresectable Locally Advanced Pancreatic Cancer With Irreversible Electroporation (IRE) System

Pilot Study of Navigated Focused Ultrasound and Pembrolizumab in the Treatment of Recurrent WHO Grade 4 IDH-Wildtype Glioblastoma With Mismatch Repair Deficiency

Safety and Efficacy of Bevacizumab in Combination With NaviFUS System for the Treatment of Recurrent Glioblastoma Multiforme (rGBM)

Contrast-Enhanced Ultrasound Identification of Sentinel Nodes in Esophageal Cancer

THRIVE- THerapeutic IntravasculaR Ultrasound (TIVUS™) REnal Denervation System Versus Sham for the Adjunctive Treatment of Hypertension

Longitudinal Evaluation of HIV-associated Lung Disease Phenotypes

Evaluation of EnVisio SmartClip for Intraoperative Localization of Breast Masses

Feasibility Study: Histological Characterization After Treatment With the Ulthera® System

The Effects of Ultrasound on Central Nervous System

The Cancer of the Pancreas Screening-5 CAPS5)Study

Bedside Ultrasound of Gastric Contents in Pediatric Populations

WATER IV PCa (AS Sub-study)